Novel ADCs in Breast Cancer
Expert Perspectives on Novel and Emerging HER2-Directed and TROP-2‒Targeted ADCs for Advanced Breast Cancer

Released: May 02, 2024

Expiration: May 01, 2025

Activity

Progress
1
Course Completed

In this commentary, Kevin Kalinsky, MD, MS, engages learners on Twitter/X in a question and answer session and provides real-word perspectives on novel and emerging ADCs in the management of patients with advanced breast cancer.

 

Image 1:

Image 2:

Image 3:

Image 4:

Image 5:

Image 6:

Image 7:

Image 8: